Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Total Debt (2018 - 2025)

Dna X filings provide 7 years of Total Debt readings, the most recent being $171000.0 for Q4 2025.

  • On a quarterly basis, Total Debt changed N/A to $171000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $171000.0, a N/A change, with the full-year FY2025 number at $171000.0, changed N/A from a year prior.
  • Total Debt hit $171000.0 in Q4 2025 for Dna X, down from $250000.0 in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $566000.0 in Q1 2025 to a low of $37000.0 in Q3 2023.
  • Median Total Debt over the past 4 years was $181000.0 (2022), compared with a mean of $209714.3.
  • Biggest five-year swings in Total Debt: plummeted 96.88% in 2021 and later dropped 26.69% in 2022.
  • Dna X's Total Debt stood at $214000.0 in 2021, then plummeted by 31.31% to $147000.0 in 2022, then plummeted by 74.83% to $37000.0 in 2023, then soared by 362.16% to $171000.0 in 2025.
  • The last three reported values for Total Debt were $171000.0 (Q4 2025), $250000.0 (Q3 2025), and $566000.0 (Q1 2025) per Business Quant data.